Clinical Conversations (CE): GLP Practice Insights: GLP-1 Receptor Agonists and Muscle Loss (CE)
About this episode
The episode discusses the concerns of muscle loss related to GLP-1 receptor agonist therapy and emphasizes strategies for muscle preservation.
This podcast explores the growing concern of muscle loss associated with GLP-1 receptor agonist therapy for obesity management. It highlights the need for greater awareness among clinicians and patients, emphasizing strategies such as adequate protein intake, strength training, and emerging pharmacologic options to preserve muscle mass. The discussion underscores the importance of muscle preservation for long-term health and quality of life in individuals using GLP-1 therapies. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
More episodes of ASHPOfficial
- Rolling the Dice with Biosafety: Pharmacy Best Practices for the Safe Handling and Management of Live Therapeutics
- Hot Topics/Clinical Conversations: SCPP: Outpatient Pharmacy Continuous Glucose Monitoring Service: A Pilot Program
- Clinical Conversations: SCSS: Practice Transformation: Making eGFR the Standard for CKD Dosing
- Pharmacy Leadership: Caring for Yourself While Caring for Patients: Micro Strategies for Wellness
Explore listener stats, chart rankings, contacts and more on the ASHPOfficial podcast page.